PDE5i Use Linked to Post-LVAD Right Heart Failure Events

WEDNESDAY, June 12, 2019 -- For left ventricular assist device (LVAD) recipients, those on phosphodiesterase-5 inhibitors (PDE5i) have a higher incidence of severe early right heart failure (RHF), according to a study published online June 11 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news